Related Experiment Video
Updated: Jan 9, 2026

Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport
Published on: June 28, 2014
Rationally engineered cyclodextrins: smart shuttles for neurological drug targeting and BBB modulation
Mokhtar Rejili1, Gaurav Gupta2, Sachin Kumar Singh3
1Department of Biology, College of Sciences, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
Cyclodextrins (CDs) enhance drug delivery across the blood-brain barrier (BBB) for neurodegenerative disorders. These cyclic oligosaccharides improve drug solubility and neuroprotection by modulating cell membranes and mitochondrial function.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- The blood-brain barrier (BBB) limits drug efficacy in treating neurodegenerative diseases due to its selective permeability.
- Conventional drugs often face challenges with solubility and accessing neural targets.
- Neurodegenerative disorders require innovative therapeutic strategies to overcome biological barriers.
Purpose of the Study:
- To review the mechanisms of cyclodextrin (CD)-based drug delivery systems for overcoming BBB limitations.
- To explore how CDs enhance drug solubility, biodistribution, and neuroprotection.
- To discuss the potential of CDs in treating neurodegenerative pathologies.
Main Methods:
- Review of contemporary literature on CD-based drug delivery systems.
- Analysis of CD supramolecular structure and inclusion complex formation.
- Examination of CD interactions with cell membranes, lipids, and transporters.
Main Results:
- CDs form inclusion complexes, enhancing solubility and pharmacokinetics of lipophilic drugs.
- CDs demonstrate neuroprotective effects by modulating membrane lipids, autophagy, and mitochondrial function.
- CDs show potential in traversing the BBB and modulating key pathological processes like neuroinflammation and protein aggregation.
Conclusions:
- CDs offer a promising therapeutic paradigm for neurodegenerative diseases by improving drug delivery and providing inherent neuroprotection.
- Understanding CD-drug conjugate mechanisms, membrane interactions, and transporter effects is crucial for optimizing their use.
- CDs represent a versatile platform for developing novel neurotherapeutics.
Related Concept Videos
The Blood-brain Barrier
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.

